E. M. Molnar

924 total citations
43 papers, 735 citations indexed

About

E. M. Molnar is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Epidemiology. According to data from OpenAlex, E. M. Molnar has authored 43 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 7 papers in Pediatrics, Perinatology and Child Health and 7 papers in Epidemiology. Recurrent topics in E. M. Molnar's work include Drug Transport and Resistance Mechanisms (12 papers), Nanoparticle-Based Drug Delivery (5 papers) and Pharmacological Effects and Toxicity Studies (5 papers). E. M. Molnar is often cited by papers focused on Drug Transport and Resistance Mechanisms (12 papers), Nanoparticle-Based Drug Delivery (5 papers) and Pharmacological Effects and Toxicity Studies (5 papers). E. M. Molnar collaborates with scholars based in Hungary, United Kingdom and Russia. E. M. Molnar's co-authors include Eugen Barbu, John Tsibouklis, Dariusz C. Górecki, Péter Krajcsi, Tamás Janáky, Emese Kis, Hristos Glavinas, Tünde Nagy, Krisztina Herédi‐Szabó and Lajos Szente and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Pharmacology and Experimental Therapeutics and Annals of the Rheumatic Diseases.

In The Last Decade

E. M. Molnar

36 papers receiving 708 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. M. Molnar Hungary 12 295 203 164 129 109 43 735
Varun Khurana United States 16 190 0.6× 332 1.6× 187 1.1× 211 1.6× 65 0.6× 22 893
J P Andreux France 15 125 0.4× 323 1.6× 155 0.9× 91 0.7× 40 0.4× 24 930
Mirte M. Malingré Netherlands 16 610 2.1× 199 1.0× 176 1.1× 222 1.7× 306 2.8× 28 1.1k
Sarinj Fattah Ireland 10 171 0.6× 160 0.8× 48 0.3× 148 1.1× 75 0.7× 17 510
Sylvain Poujol France 16 286 1.0× 239 1.2× 94 0.6× 40 0.3× 64 0.6× 36 796
Makoto Haga Japan 14 87 0.3× 246 1.2× 75 0.5× 93 0.7× 41 0.4× 50 602
Ramya Krishna Vadlapatla United States 19 153 0.5× 366 1.8× 85 0.5× 95 0.7× 58 0.5× 29 878
Patricia García‐López Mexico 20 191 0.6× 469 2.3× 135 0.8× 46 0.4× 34 0.3× 54 1.1k
Yulian Lin China 12 162 0.5× 347 1.7× 66 0.4× 210 1.6× 64 0.6× 18 673
Thomas F. Patton United States 18 323 1.1× 489 2.4× 75 0.5× 718 5.6× 100 0.9× 34 1.8k

Countries citing papers authored by E. M. Molnar

Since Specialization
Citations

This map shows the geographic impact of E. M. Molnar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. M. Molnar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. M. Molnar more than expected).

Fields of papers citing papers by E. M. Molnar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. M. Molnar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. M. Molnar. The network helps show where E. M. Molnar may publish in the future.

Co-authorship network of co-authors of E. M. Molnar

This figure shows the co-authorship network connecting the top 25 collaborators of E. M. Molnar. A scholar is included among the top collaborators of E. M. Molnar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. M. Molnar. E. M. Molnar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jani, Márton, et al.. (2018). Correlation Analysis of Potential Breast Cancer Resistance Protein Probes in Different Monolayer Systems. Journal of Pharmaceutical Sciences. 107(11). 2742–2747. 1 indexed citations
2.
Erdő, Franciska, et al.. (2017). Abcb1a (P-glycoprotein) limits brain exposure of the anticancer drug candidate seliciclib in vivo in adult mice. Brain Research Bulletin. 132. 232–236. 5 indexed citations
3.
Katona, Éva, et al.. (2017). Factor XIII levels and factor XIII B subunit polymorphisms in patients with venous thromboembolism. Thrombosis Research. 158. 93–97. 12 indexed citations
4.
Katona, Ëva, Zsuzsanna Bereczky, E. M. Molnar, et al.. (2016). Regulation of plasma factor XIII levels in healthy individuals; a major impact by subunit B intron K c.1952+144 C>G polymorphism. Thrombosis Research. 148. 101–106. 7 indexed citations
5.
Nagy, Zoltán, et al.. (2016). Species specificity profiling of rat and human organic cation/carnitine transporter Slc22a5/SLC22A5 (Octn2/OCTN2). Drug Metabolism and Pharmacokinetics. 32(3). 165–171. 11 indexed citations
6.
Molnar, E. M., et al.. (2015). Ocorrência da Brucella canis e Brucella obortus em cães criados no Estado do Pará. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 69–76. 1 indexed citations
7.
Toman, Petr, Zeeshan Ahmad, Susanne Dietrich, et al.. (2015). Nanoparticles of alkylglyceryl-dextran-graft-poly(lactic acid) for drug delivery to the brain: Preparation and in vitro investigation. Acta Biomaterialia. 23. 250–262. 44 indexed citations
8.
Nagy, Zoltán, et al.. (2013). Chlorothiazide is a Substrate for the Human Uptake Transporters OAT1 and OAT3. Journal of Pharmaceutical Sciences. 102(5). 1683–1687. 10 indexed citations
9.
Barbu, Eugen, E. M. Molnar, John Tsibouklis, & Dariusz C. Górecki. (2009). The potential for nanoparticle-based drug delivery to the brain: overcoming the blood–brain barrier. Expert Opinion on Drug Delivery. 6(6). 553–565. 180 indexed citations
10.
Fenyvesi, Ferenc, Éva Fenyvesi, Lajos Szente, et al.. (2008). P-glycoprotein inhibition by membrane cholesterol modulation. European Journal of Pharmaceutical Sciences. 34(4-5). 236–242. 65 indexed citations
11.
Nagy, Tünde, E. M. Molnar, Judit Jánossy, et al.. (2008). Leflunomide and its metabolite A771726 are high affinity substrates of BCRP: implications for drug resistance. Annals of the Rheumatic Diseases. 68(7). 1201–1207. 57 indexed citations
12.
Herédi‐Szabó, Krisztina, et al.. (2008). Characterization of 5(6)-Carboxy-2,′7′-Dichlorofluorescein Transport by MRP2 and Utilization of this Substrate as a Fluorescent Surrogate for LTC4. SLAS DISCOVERY. 13(4). 295–301. 39 indexed citations
13.
Pál, Ákos, Dóra Méhn, E. M. Molnar, et al.. (2007). Cholesterol Potentiates ABCG2 Activity in a Heterologous Expression System: Improved in Vitro Model to Study Function of Human ABCG2. Journal of Pharmacology and Experimental Therapeutics. 321(3). 1085–1094. 90 indexed citations
14.
Glavinas, Hristos, Emese Kis, Ákos Pál, et al.. (2007). ABCG2 (Breast Cancer Resistance Protein/Mitoxantrone Resistance-Associated Protein) ATPase Assay: A Useful Tool to Detect Drug-Transporter Interactions. Drug Metabolism and Disposition. 35(9). 1533–1542. 56 indexed citations
15.
Сухих, Г. Т., et al.. (1994). Experimental treatment of habitual abortion of adrenal etiology by transplantation of a tissue culture of newborn pig adrenals. Bulletin of Experimental Biology and Medicine. 117(4). 389–391. 1 indexed citations
16.
Molnar, E. M., et al.. (1994). Status of the breasts in patients with the postcastration syndrome treated by transplantation of human fetal tissue. Bulletin of Experimental Biology and Medicine. 117(4). 387–389.
17.
Glávits, R., et al.. (1984). Pathological studies in chicken embryos and day-old chicks experimentally infected with avian reovirus.. PubMed. 32(1-2). 23–37. 3 indexed citations
18.
Nagy, Gábor, et al.. (1977). Simple ion exchange batch technique for detection of IgM antibodies against rubella and flavivirus antigens.. 24(4). 317–321. 4 indexed citations
19.
Sinkovics, J. G. & E. M. Molnar. (1954). Studies on the infectivity of influenza virus multiplying in the mouse lung.. PubMed. 2(1-2). 195–9. 1 indexed citations
20.
Molnar, E. M., et al.. (1954). [Isolation of encephalomyelitis virus from ticks. I. Isolation of the virus and its properties].. PubMed. 95(6). 144–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Varun Khurana Breakdown of academic impact, for papers by J P Andreux Breakdown of academic impact, for papers by Mirte M. Malingré Breakdown of academic impact, for papers by Sarinj Fattah Breakdown of academic impact, for papers by Sylvain Poujol Breakdown of academic impact, for papers by Makoto Haga Breakdown of academic impact, for papers by Ramya Krishna Vadlapatla Breakdown of academic impact, for papers by Patricia García‐López Breakdown of academic impact, for papers by Yulian Lin Breakdown of academic impact, for papers by Thomas F. Patton
Rankless by CCL
2026